Orrell R W, King A W, Hilton D A, Campbell M J, Lane R J, de Belleroche J S
Department of Biochemistry, Charing Cross Hospital, London, UK.
J Neurol Neurosurg Psychiatry. 1995 Sep;59(3):266-70. doi: 10.1136/jnnp.59.3.266.
Mutations of SOD-1 have recently been associated with autosomal dominant familial amyotrophic lateral sclerosis (ALS). A patient is described with a 20 year duration of motor neuron disease, with clinical features of ALS, who was heterozygous for a point mutation ATT to ACT leading to substitution of isoleucine for threonine at codon 113 in exon 4 of SOD-1. This mutation has previously been described in two families with ALS and three apparently sporadic cases of ALS. The patient described here had a family history suggestive of autosomal dominant inheritance of this genetic mutation; other members of the family having a more typical disease duration. Unusual pathological features included neurofibrillary tangles in neurons of the globus pallidus, substantia nigra, locus coeruleus, and inferior olivary nuclei, and absence of ubiquitin immunoreactive inclusions in motor neurons. This may reflect the slow progression of the neurodegeneration associated with the SOD-1 mutation in this patient. The prolonged survival, of over 20 years, with other family members having a more typical survival of two to three years, has important implications for genetic counselling in families with ALS in addition to the fundamental biological questions concerning the influence of these mutations on disease expression.
超氧化物歧化酶1(SOD-1)的突变最近被认为与常染色体显性遗传的家族性肌萎缩侧索硬化症(ALS)有关。本文描述了一位患有运动神经元疾病20年的患者,其具有ALS的临床特征,该患者SOD-1基因第4外显子113密码子处存在一个点突变,由ATT突变为ACT,导致异亮氨酸被苏氨酸替代,呈杂合状态。此突变先前在两个ALS家族及三例明显散发的ALS病例中被描述过。本文所描述的患者有家族史提示该基因突变呈常染色体显性遗传;家族中的其他成员病程更为典型。不寻常的病理特征包括苍白球、黑质、蓝斑及下橄榄核神经元中的神经原纤维缠结,以及运动神经元中缺乏泛素免疫反应性包涵体。这可能反映了该患者中与SOD-1突变相关的神经退行性变进展缓慢。该患者存活超过20年,而其他家族成员的典型存活期为两到三年,这除了对这些突变对疾病表现的影响这一基本生物学问题外,对ALS家族的遗传咨询也具有重要意义。